Xi jfisser "Ċar"?
L-annimal ma jġorrx il-mutazzjoni. Mhux se tiżviluppa l-marda u mhux se jgħaddiha.
The DNA test for Neuronal Ceroid Lipofuscinosis 8 (NCL8) in Setter dogs is essential for early detection of this inherited neurological disorder. NCL8 causes progressive brain degeneration, leading to severe symptoms and reduced lifespan in affected dogs. By using this genetic test, breeders can identify carriers and avoid breeding affected puppies, promoting healthier bloodlines. Early diagnosis through DNA testing helps manage the disease and improve the quality of life for Setters. This test is a vital tool for responsible breeding programs focused on preventing NCL8. Ensure your Setter’s health by opting for the NCL8 DNA test today. Protect your dog’s future with accurate genetic screening.
Neuronal Ceroid Lipofuscinosis 8 (NCL8) is a genetic disorder affecting Setters, caused by mutations that lead to the accumulation of lipofuscin in nerve cells. This progressive disease results in neurological decline, including seizures, vision loss, and motor dysfunction. A DNA test for NCL8 helps identify carriers and affected dogs, enabling responsible breeding decisions. Early detection through genetic screening can prevent the spread of this debilitating condition. Responsible breeders use this test to promote healthier Setter populations.
Dan it-test tad-DNA huwa inkluż li jibda mill-pakkett tagħna Basic — u huwa wkoll parti mill-pakketti Basic, Standard, Advanced, Complete.
Ara l-Pakketti tat-Test tad-DNA →Neuronal Ceroid Lipofuscinosis 8 (NCL8-Se) is a genetic disorder that primarily affects the nervous system of dogs, particularly those of the Setter breed. This condition is part of a broader group of lysosomal storage diseases, which are characterized by the accumulation of lipopigments in the neurons and other tissues. NCL8-Se is caused by mutations in specific genes that lead to the disruption of normal cellular processes, ultimately resulting in neurodegeneration.
The clinical presentation of NCL8-Se can vary, but it typically manifests as a progressive decline in neurological function. Common symptoms include vision loss, behavioral changes, seizures, and motor difficulties. As the disease progresses, affected dogs may exhibit signs of confusion, disorientation, and difficulty in performing everyday activities. The onset of symptoms usually occurs in the later stages of life, making early detection challenging for pet owners and veterinarians.
NCL8-Se is a consequence of the body’s inability to properly break down and clear lipopigments, specifically ceroid and lipofuscin, which accumulate within neuronal cells. This accumulation leads to cellular dysfunction and death, particularly in areas of the brain responsible for vision, movement, and cognitive function. The neuronal loss is irreversible, ultimately resulting in the clinical symptoms associated with the disorder.
Diagnosis of Neuronal Ceroid Lipofuscinosis 8 is typically confirmed through genetic testing, which identifies the specific mutations responsible for the condition. Observational evaluations by veterinary professionals can also provide insights into the neurological status of the dog, often leading to further testing. Blood tests and advanced imaging techniques can assist in ruling out other potential causes of the observed symptoms, but definitive diagnosis relies on genetic analysis.
Currently, there is no cure for NCL8-Se; however, supportive care can help manage the symptoms and improve the quality of life for affected dogs. This may include a specialized diet, medications to control seizures, and modifications to the home environment to accommodate mobility challenges. Regular veterinary check-ups are essential to monitor the progression of the disease and adjust care strategies as needed.
Neuronal Ceroid Lipofuscinosis 8 is a serious genetic disorder that poses significant challenges for affected dogs and their owners. Understanding the condition, its symptoms, and management options is crucial for providing the best possible care. While there is currently no cure, awareness and early diagnosis can lead to more effective supportive measures, ultimately enhancing the quality of life for dogs living with this condition.
L-annimal ma jġorrx il-mutazzjoni. Mhux se tiżviluppa l-marda u mhux se jgħaddiha.
Le. L-annimal huwa ġeneralment b'saħħtu iżda jista 'jitrażmetti l-mutazzjoni lil tiegħu frieħ.
Ġorr żewġ kopji mutati. Sinjali kliniċi huma mistennija jiddependi fuq il-marda. M'għandux ikun imrobbi.
Xi mard huwa marbut mas-sess, għalhekk l-espressjoni tagħhom tvarja skond il- sess tal-annimal.
This DNA test detects the mutation associated with Neuronal Ceroid Lipofuscinosis 8 In Setter (NCL8-Se) in order to identify clear, carrier, or at-risk animals.
L-ittestjar tad-DNA jgħin lil dawk li jrabbu jippjanaw tgħammir aktar sigur u jnaqqsu r-riskju li jittrażmettu l-mutazzjoni lill-frieħ.
Il-mod ta' wirt irrappurtat għal dan it-test huwa Awtosomali Reċessiv.
This test analyses the mutation CLN8 c.491T>C.
Mhux bilfors. L-interpretazzjoni tiddependi fuq il-mudell tal-wirt u l-ġenotip li jirriżulta.
Katz Martin L, Khan Shahnawaz, Awano Tomoyuki, Shahid S Adam, Siakotos Aristotle N, Johnson Gary S. A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis. Biochem Biophys Res Commun. 2005 Feb 11;327(2):541-7. doi: 10.1016/j.bbrc.2004.12.038.
Il-privatezza tiegħek, l-għażla tiegħek
Aħna nużaw cookies essenzjali biex inħaddmu l-websajt. Il-cookies fakultattivi (bħal fornituri ta' kontenut inkorporat) huma diżattivati b'mod awtomatiku u huma attivati biss jekk taqbel. Tista' tibdel l-għażla tiegħek f'kull ħin billi tuża l-buttuna "Cookies".
Meħtieġa għall-karatteristiċi ewlenin u s-sigurtà. Dejjem attivat.
Ittejjeb il-karatteristiċi bħall-iffrankar tal-preferenzi jew inkorporazzjonijiet mhux ta' reklamar.
Jgħinna nifhmu l-użu tas-sit. B'diżabilita' awtomatikament.
Reklamar/traċċar fuq is-siti (xi vidjow/mapep inkorporati). B'diżabilita' awtomatikament.